Detail

Keywords

Biliary Tract Neoplasms; Gastrointestinal Neoplasms; Medical Oncology; Molecular Targeted Therapy

Research group(s)

• Gerald Prager Research Group
  Research Area: Two main research areas 1) Precision Medicine in Oncology 2) Expertise in hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, colorectal cancer, anal cancer
  Members:
  Hossein Taghizadeh
• Research Group GI Cancer
  Members:
  Hossein Taghizadeh

Research interests

Our main research focus is on precision medicine in oncology.

We intend to assess the possiblity, the feasibility and the efficacy of molecular guided treatment approaches in advanced therapy-refractory cancer diseases.

Techniques, methods & infrastructure

Clinical Research

Selected publications

1. Taghizadeh, H. et al. (2020) ‘Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform’, The Oncologist, 25(7), pp. e1060–e1069. Available at: http://dx.doi.org/10.1634/theoncologist.2019-0904.
2. Taghizadeh, H. et al. (2020) ‘Applied precision cancer medicine in metastatic biliary tract cancer’, Hepatology International, 14(2), pp. 288–295. Available at: http://dx.doi.org/10.1007/s12072-020-10020-6.
3. Taghizadeh, H. et al. (2019) ‘Applied Precision Cancer Medicine in Neuro-Oncology’, Scientific Reports, 9(1). Available at: http://dx.doi.org/10.1038/s41598-019-56473-0.